The Critical Role of Pain Management and Wound Care in Hidradenitis Suppurativa
At the 2026 ODAC conference in Orlando, renowned expert Dr. Hadar Lev-Tov delivered an insightful presentation on the critical aspects of managing Hidradenitis Suppurativa (HS), focusing on two often-overlooked areas: pain management and wound care. This summary captures the key takeaways and clinical pearls from Dr. Lev-Tov's lecture.
The Critical Role of Pain Management in HS
Dr. Lev-Tov began …
At the 2026 ODAC conference in Orlando, renowned expert Dr. Hadar Lev-Tov delivered an insightful presentation on the critical aspects of managing Hidradenitis Suppurativa (HS), focusing on two often-overlooked areas: pain management and wound care. This summary captures the key takeaways and clinical pearls from Dr. Lev-Tov's lecture.
The Critical Role of Pain Management in HS
Dr. Lev-Tov began … Continue reading "The Critical Role of Pain Management and Wound Care in Hidradenitis Suppurativa"
Scarring alopecias can be especially distressing for a patient and challenging for a clinician to treat. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Susan C. Taylor, Bernett Johnson Endowed Professor of Dermatology at the University of Pennsylvania Perelman School of Medicine. Watch as Dr. Taylor outlines how a deeper understanding of scarring alopecias is impact … 
Sulfur–sulfacetamide is a long-standing topical therapy in dermatology valued for its combined antimicrobial, anti-inflammatory, and keratolytic effects. It is commonly used for several conditions including acne vulgaris, papulopustular rosacea, and seborrheic dermatitis. Although newer targeted therapies are often preferred for rosacea, sulfur–sulfacetamide remains a practical option, especia … 
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in … 
Dr. Mona Shahriari, associate clinical professor of dermatology at Yale University School of Medicine, encourages clinicians to broaden their psoriasis color palette. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Shahriari, who outlined how to diagnose psoriasis in patients with darker skin tones. Learn the domains of psoriatic arthritis and how that knowledge can …